Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | PAR 20 237

FAQs: NIH PAR-20-237 - Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 - Clinical Trial Optional)

What is the purpose of NIH funding opportunity PAR-20-237?

PAR-20-237 supports research that puts community-level interventions into practice and rigorously evaluates how well they work. The aim is to generate evidence that reduces COVID-19 related harms in populations experiencing health disparities and in other vulnerable groups, with a strong emphasis on real-world community settings rather than purely clinical or laboratory environments.

What type of grant mechanism is PAR-20-237?

This funding opportunity uses the NIH R01 mechanism, which is designed for substantial, multi-year research projects that can produce actionable findings.

Are clinical trials required under this opportunity?

No. The FOA is "Clinical Trial Optional," meaning applicants may propose either clinical trial or non-clinical trial approaches, depending on what best fits the intervention and the evaluation plan.

What kinds of projects does this FOA prioritize?

The FOA prioritizes projects that implement and evaluate community interventions addressing COVID-19 impacts in health disparity and vulnerable populations. It emphasizes measuring effectiveness and real-world performance, including feasibility, reach, and equity impact.

What are the two main focus areas highlighted in the FOA?

The FOA highlights two broad areas: (1) community-level mitigation strategies intended to prevent COVID-19 transmission within NIH-designated health disparity populations and other vulnerable groups, and (2) interventions that address broader psychosocial, behavioral, and socioeconomic consequences of the pandemic beyond infection itself.

What are examples of COVID-19 mitigation interventions that could fit this FOA?

Examples mentioned include community-based prevention strategies to improve masking uptake, increase testing access and acceptability, support safer workplace or congregate-setting practices, strengthen communication and trust in public health guidance, and improve access to vaccination services and related supports. The FOA emphasizes evaluating these strategies in terms of effectiveness, feasibility, reach, and equity.

What does the FOA mean by addressing consequences beyond infection?

It refers to interventions targeting the psychosocial, behavioral, and socioeconomic fallout of the pandemic that can worsen health and widen inequities. The FOA is interested in what works to buffer or reverse these harms in communities with heightened vulnerability.

What types of outcomes are contemplated for projects addressing broader pandemic consequences?

The FOA describes outcomes such as mental health effects (stress, depression, anxiety, grief, social isolation), behavioral changes (substance use, physical activity disruptions, dietary changes, health care avoidance), and socioeconomic challenges (housing instability, food insecurity, job loss, childcare barriers, reduced access to education or community resources).

Can projects evaluate interventions that are already in place, or do they need to be new?

The FOA supports evaluating already implemented interventions, completely new interventions, or adaptations of existing programs modified to fit pandemic realities.

Is the emphasis more on implementing programs or on evaluation?

Both matter, but the FOA is explicit that projects should not only implement interventions; they should also rigorously evaluate them. The goal is evidence generation that can guide real-world decision-making and equity-focused scaling.

What setting does NIH want these interventions to be implemented in?

The FOA emphasizes real-world community settings rather than purely clinical or laboratory environments, reflecting its focus on community realities and practical implementation.

Who is the intended population focus?

The FOA targets NIH-designated health disparity populations and other vulnerable populations that have been disproportionately affected by COVID-19 and its downstream impacts.

What does "health disparity and vulnerable populations" imply in the context of this FOA?

In this FOA, it implies communities that experience disproportionate COVID-19 burdens and inequitable outcomes, and where interventions must be designed and tested in ways that are culturally and contextually appropriate to reduce inequities.

What activity areas does this discretionary grant opportunity span?

The opportunity spans activity categories including education, environment, food and nutrition, and health, reflecting the cross-cutting ways the pandemic has affected communities.

Does the FOA suggest multi-sector partnerships?

Yes. The cross-cutting categories and community-setting emphasis indicate that strong proposals may involve multi-sector partnerships (for example, connections spanning health, education, housing, food systems, and community services).

What is the listed award ceiling?

The listing includes an award ceiling of $500,000. The description notes that this typically indicates an upper limit on annual direct costs or total costs depending on FOA specifics, and applicants generally confirm the exact budgeting rules in the full announcement and NIH policy guidance.

When was this funding opportunity created, and what is the closing date shown?

The creation date shown is June 17, 2020, and the original closing date shown is December 1, 2020.

Who can apply for PAR-20-237?

Eligibility is broad and includes many types of U.S.-based organizations, such as state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized governments; nonprofits with and without 501(c)(3) status (excluding institutions of higher education when categorized separately); for-profit organizations other than small businesses; and small businesses.

Does the FOA explicitly encourage applications from certain institutions and community organizations?

Yes. It explicitly names Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible agencies of the federal government, Indian/Native American tribal governments other than federally recognized ones, and U.S. territories or possessions.

Are faith-based organizations eligible to apply?

Yes. Faith-based or community-based organizations are explicitly listed as eligible applicants.

Are for-profit organizations eligible to apply?

Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are explicitly listed among additional eligible applicants.

Are foreign (non-U.S.) organizations eligible to apply as the applicant organization?

No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization.

Can a non-domestic (non-U.S.) component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are not eligible to apply.

Are any foreign components allowed in projects under this FOA?

Yes. Foreign components are allowed as defined in the NIH Grants Policy Statement. This means a U.S.-based applicant may include certain international elements or collaborations if they meet NIH requirements and are well justified, even though a foreign institution cannot be the primary applicant.

What does "multiple CFDA numbers" imply for this opportunity?

The listing includes multiple CFDA numbers (now commonly referred to as Assistance Listings), which signals that several NIH institutes and centers may be participating or that the opportunity intersects with multiple NIH funding lines.

What distinguishes a competitive project under this FOA, based on the description provided?

Based on the FOA description, competitive projects would typically be expected to show strong community engagement, culturally and contextually appropriate intervention design, a credible evaluation strategy with clear outcome measures, and a practical implementation plan for real-world settings where results can be applied and scaled to improve equity.

Is the FOA focused on describing disparities or testing solutions?

The FOA is focused on moving beyond describing disparities to testing community-centered solutions, with rigorous evaluation to determine what works to reduce transmission risk and address the mental, behavioral, and economic harms of COVID-19 in disproportionately affected groups.